- Rho-Kinase as a Therapeutic Target for Nonalcoholic Fatty Liver Diseases
-
Sousa-Lima I, Kim HJ, Jones J, Kim YB
- KMID: 2520849
- Diabetes Metab J.
- 2021 Sep;45(5):655-674.
- doi: 10.4093/dmj.2021.0197
Nonalcoholic fatty liver disease (NAFLD) is a major public health problem and the most common form of chronic liver disease, affecting 25% of the global population. Although NAFLD is closely... -
- CITED
-
- Close
- SHARE
-
- Close
